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The prion diseases occur following the conversion of the cel-
lular prion protein (PrPC) into disease-related isoforms (PrPSc).
In this study, the role of the glycosylphosphatidylinositol (GPI)
anchor attached to PrPC in prion formationwas examined using
a cell painting technique. PrPSc formation in two prion-infected
neuronal cell lines (ScGT1 and ScN2a cells) and in scrapie-in-
fected primary cortical neurons was increased following the
introduction of PrPC. In contrast, PrPC containing aGPI anchor
fromwhich the sialic acid had been removed (desialylated PrPC)
was not converted to PrPSc. Furthermore, the presence of desia-
lylated PrPC inhibited the production of PrPSc within prion-
infected cortical neurons andScGT1andScN2a cells. Themem-
brane rafts surrounding desialylated PrPC contained greater
amounts of sialylated gangliosides and cholesterol than mem-
brane rafts surrounding PrPC. Desialylated PrPC was less sensi-
tive to cholesterol depletion than PrPC and was not released
from cells by treatment with glimepiride. The presence of desia-
lylated PrPC in neurons caused the dissociation of cytoplasmic
phospholipase A2 from PrP-containing membrane rafts and
reduced the activation of cytoplasmic phospholipase A2. These
findings show that the sialic acid moiety of the GPI attached to
PrPC modifies local membrane microenvironments that are
important in PrP-mediated cell signaling and PrPSc formation.
These results suggest that pharmacological modification of GPI
glycosylation might constitute a novel therapeutic approach to
prion diseases.
The prion diseases are fatal neurodegenerative disorders that
include scrapie in sheep and goats, bovine spongiform enceph-
alopathy in cattle, and Creutzfeldt-Jakob disease in man. A key
event in these diseases is the conversion of a normal host pro-
tein designated PrPC into disease-associated isoforms (PrPSc).
In this conversion process, a portion of PrPC that is mostly
-helix and random coil becomes refolded into a -pleated
sheet in the PrPSc molecule (1). Although the presence of PrPC
is essential for prion formation (2), not all cells that express
PrPC are permissive for PrPSc replication. The reasons why
some cells that express PrPC do not replicate PrPSc are not fully
understood. Reports that the targeting of PrPC to specificmem-
branes is required for efficient PrPSc formation (3, 4) indicate
that factors that affect the cellular targeting and intracellular
trafficking of PrPC are critical in determining PrPSc replication.
Themajority of PrPCmolecules are linked to membranes via
a glycosylphosphatidylinositol (GPI)2 anchor (5). GPI anchors
play a complex role in the regulation of cell membrane compo-
sition, cell signaling and protein trafficking (6). For example,
the presence of aGPI anchor targets PrPC to specificmembrane
microdomains called rafts that are required for efficient PrPSc
formation (3, 4). The role of the GPI anchor in prion diseases is
controversial because transgenic mice that produce anchorless
PrPC produce large amounts of soluble PrPSc (7), suggesting
that the GPI anchor was not essential for PrPSc formation. In
contrast, observations that neuronal cells producing anchorless
PrPC were resistant to scrapie infection (8) and that monoacy-
lated PrPC was not converted to PrPSc within neuronal cells (9)
indicate that the GPI is a critical factor in facilitating mem-
brane-associated PrPSc formation.
GPI-anchored molecules, including PrPC, are rapidly incor-
porated into living cells (10, 11), and introducing PrPC to prion
infected cells by cell painting increased PrPSc formation (9).
This technique was used to examine the role of specific GPI
structures on PrPC and PrPSc formation. The GPI anchor
attached to PrPC is unusual among mammalian GPIs in that it
contains sialic acid (12). Neuraminidase digestion was used to
produce a PrPC with a GPI anchor lacking sialic acid (desialy-
lated PrPC), a modification that could not be achieved by
genetic manipulation methods (13). We report three major
observations: first, that desialylated PrPC behaves differently
fromPrPCwith regards to its effects onmembrane composition
and cell signaling; second, that desialylated PrPC is not con-
verted to PrPSc; and third, that desialylated PrPC inhibits the
conversion of endogenous PrPC to PrPSc.
Experimental Procedures
Cell Lines—Prion-infected ScN2a and ScGT1 cells were
grown in Ham’s F-12 medium containing 2 mM glutamine and
2% fetal calf serum. To determine the effect of test preparations
on PrPSc formation, ScN2a or ScGT1 cells were added to 6-well
plates, allowed to adhere overnight, and then cultured in the
presence or absence of test PrPC preparations. The cells were
grown with daily changes of media ( PrPC preparations), and
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the amounts of PrPSc were evaluated after 7 days. In other
experiments, ScGT1 and ScN2a cells were pretreated for 1 h
with control medium or desialylated PrPC and then incubated
with phospholipase A2-activating peptide (PLAP) (Bachem) for
a further 1 h.
Primary Neurons—Cortical neurons were prepared from the
brains of mouse embryos (day 15.5) derived from Prnp wild
type(/) and Prnp knock-out(0/0) mice after mechanical disso-
ciation. Neurons (106) were added to 6-well plates that had
been coated with poly-L-lysine and incubated in Ham’s F-12
medium containing 5% fetal calf serum for 2 h. Cultures were
shaken (600 rpm for 5 min), and nonadherent cells were
removed by two washes in PBS. Neurons were grown in neuro-
basal medium containing B27 components and 5 ng/ml nerve
growth factor (Sigma) for 10 days. Immunostaining showed
that the cells were greater than 95% neurofilament-positive. In
some experiments, neurons were pretreated for 24 h with
squalestatin (GlaxoSmithKline). The fate of PrPC preparations
was determined by incubating neurons with 10 ng of PrPC or
desialylated PrPC. Cells were washed to remove unbound PrPC
and incubated in fresh culture medium for different time peri-
ods. For infection studies, neurons from either Prnp(0/0) or
Prnp(/) mice were pulsed with 1 ng of PrPSc (derived from
ScGT1 cells (14)) and then incubated with 10 ng of PrPC or 10
ng of desialylated PrPC. Media containing PrPC preparations
were replaced daily for 10 days, and the amount of PrPSc in
neurons was measured by ELISA. All experiments were per-
formed in accordance with European regulations (European
Community Council Directive, 1986, 56/609/EEC) and
approved by the local authority veterinary service/ethical
committee.
Cell Extracts—Treated cells were washed three times with
ice-cold PBS and homogenized in an extraction buffer contain-
ing 10 mM Tris-HCl, pH 7.4, 100 mMNaCl, 10 mM EDTA, 0.5%
Nonidet P-40, 0.5% sodium deoxycholate, and 0.2% SDS at 106
cells/ml, and nuclei and large fragments were removed by cen-
trifugation (1000  g for 5 min). Mixed protease inhibitors
(4-(2-aminoethyl) benzenesulfonyl fluoride hydrochloride,
aprotinin, leupeptin, bestatin, pepstatin A, and E-46) (Sigma)
and a phosphatase inhibitor mixture including PP1, PP2A,
microcystin LR, cantharidin, and p-bromotetramisole (Sigma)
were added to some membrane extracts. To determine the
amount of PrPSc in cells extracts were digested with 1 g/ml
proteinase K for 1 h at 37 °C, heated to 95 °C for 5 min, and
tested in a PrP ELISA as described (9).
Isolation of Detergent-resistant Membranes (DRMs)/Rafts—
The cellswere homogenized in an ice-cold buffer containing 1%
Triton X-100, 10 mM Tris-HCl, pH 7.2, 100 mM NaCl, 10 mM
EDTA, andmixed protease inhibitors (106 cells/ml), and nuclei
and large fragments were removed by centrifugation (1000 g
for 5 min). The supernatant was incubated on ice for 60 min
prior to further centrifugation (16,000  g for 30 min at 4 °C).
The detergent-soluble material was reserved as the normal cell
membrane. The insoluble DRMs were homogenized in extrac-
tion buffer (10 mM Tris-HCl, pH 7.4, 10 mM NaCl, 10 mM
EDTA, 0.5% Nonidet P-40, 0.5% sodium deoxycholate, and
0.2% SDS and mixed protease inhibitors. After further centrif-
ugation (10min at 16,000 g), the supernatant was collected as
the raft fraction.
Sucrose Density Gradients—Cells were harvested with a Tef-
lon scraper and homogenized in a buffer containing 250 mM
sucrose, 10 mM Tris-HCl, pH 7.2, and 1 mM EDTA, mixed pro-
tease inhibitors, 1 mM dithiothreitol. Nuclei and cell fragments
were removed by centrifugation (1000  g for 5 min). Mem-
branes were washed by centrifugation at 16,000 g for 20 min
at 4 °C and solubilized in an ice-cold buffer containing 1% Tri-
ton X-100, 10 mM Tris-HCl, pH 7.2, 150 mM NaCl and 10 mM
EDTA. 5, 10, 15, 20, 30, and 40% sucrose solutions were pre-
pared and layered to produce a gradient at 4 °C. Solubilized
membranes were layered on top and centrifuged at 50,000 g
for 18 h at 4 °C. Serial 0.8- or 0.25-ml volumes were collected
from the bottom of gradients.
Isolation of PrPC—PrPCmoleculeswere isolated frommurine
GT1 neuronal cell membranes using a combination of immu-
noaffinity columns, size exclusion chromatography (Superdex),
and reverse phase chromatography on C18 columns (Waters)
as described (9). PrPC was digested with 2 units/ml endoglyco-
sidase F (Sigma) and/or 0.2 units/ml neuraminidase (Clostrid-
ium perfringens; Sigma) for 2 h at 37 °C. TFA was added (final
concentration, 0.1%), and digested PrPC was loaded onto C18
columns. The samples were eluted under a gradient of acetoni-
trile and water containing 0.1% TFA. 1-ml samples were col-
lected, split into two, and lyophilized. One sample was solubi-
lized in an extraction buffer (as above) and tested in a PrP
ELISA. PrP-containing fractions were solubilized in culture
medium by sonication prior to use.
Test PrPSc Preparations—PrPSc preparations consisted of
supernatants collected from ScGT1 cells that were centrifuged
(500  g for 5 min) to remove cell debris and concentrated
using a 10-kDa filter (Sartorius Vivaspin). Preparations were
digested with 1 g/ml proteinase K for 1 h at 37 °C to remove
PrPC, and the remaining protease-resistant PrP was measured
by ELISA (see below). The samples were frozen at 20 °C for
storage. On the day of use, PrPSc preparations were diluted to 1
ng/ml in culturemedium and sonicated before addition to cells.
PrP ELISA—Maxisorb immunoplates (Nunc) were coated
with mAb ICSM18 and blocked with 5%milk powder. Samples
were applied and detected with biotinylated mAb ICSM35, fol-
lowed by extravidin-alkaline phosphatase and 1mg/ml 4-nitro-
phenyl phosphate (Sigma). Absorbance was measured on a
microplate reader at 405 nm, and the amount of PrP in samples
was calculated by reference to serial dilutions of recombinant
murine PrP (Prionics).
cPLA2 ELISA—Maxisorb immunoplates were coatedwith 0.5
g/ml of mouse mAb anti-cPLA2, clone CH-7 (Upstate), and
blocked. Samples were incubated for 1 h, and the amount of
cPLA2 was detected using a goat polyclonal anti-cPLA2 (Santa
Cruz Biotech) followed by biotinylated anti-goat IgG, extravi-
din-alkaline phosphatase, and 1 mg/ml 4-nitrophenyl phos-
phate. Absorbance wasmeasured at 405 nm, and the amount of
cPLA2 protein is expressed in units: 100 units  amount of
cPLA2 in extracts or immunoprecipitates from 106 untreated
cells.
Activated cPLA2 ELISA—The activation of cPLA2 is accom-
panied by phosphorylation of the 505 serine residue, which cre-
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ates a unique epitope that was measured in an ELISA using an
anti-cPLA2mAb (cloneCH-7) combinedwith rabbit polyclonal
anti-phospho-cPLA2 (Cell Signaling Technology) followed by
biotinylated anti-rabbit IgG (Dako), extravidin-alkaline phos-
phatase, and 1 mg/ml 4-nitrophenyl phosphate). Absorbance
was measured on a microplate reader at 405 nm. The results
were expressed as “units activated cPLA2” with 100 units
defined as the amount of activated cPLA2 in extracts derived
from 106 untreated cells.
Isolation and Analysis of GPIs—GPIs were isolated and ana-
lyzed as described (13). Briefly, PrPC preparations were
digested with proteinase K (100 g/ml) overnight at 37 °C.
Digested products were mixed with water-saturated butanol.
The butanol phase was collected and washed with water a fur-
ther three times before being loaded onto C18 columns. GPIs
were eluted from C18 columns under a gradient of propanol
and water. The presence of phosphatidylinositol in GPIs was
determined using mAb (5AB3-11), and specific glycans were
detected with biotinylated lectins. Isolated GPIs bound to
nitrocellulosemembranes by dot blot andwere blockedwith 5%
milk powder. Samples were probed with mAb 5AB3-11, bioti-
nylated Sambucus nigra lectin (detects terminal sialic acid res-
idues bound -2,6 or -2,3 to galactose), biotinylated conca-
navalin A (detects mannose), or biotinylated Ricinus communis
agglutinin I (detects terminal galactose) (Vector Laboratories).
Bound lectins were visualized using extravidin peroxidase and
enhanced chemiluminescence. The mAb was visualized by
incubation with a horseradish peroxidase-conjugated anti-mu-
rine IgM and chemiluminescence. In other studies, GPIs were
separated on silica gel 60 high performance thin layer chroma-
tography (HPTLC) plates in a mixture of chloroform/metha-
nol/water (10/10/3 v/v/v) and detected by mAb 5AB3-11. The
concentrations of GPIs were measured by ELISA. Maxisorb
immunoplates were coated with 0.5 g/ml concanavalin A
(binds mannose) and blocked with 5% milk powder in PBS-
Tween. Samples were added, and any bound GPI was detected
by the addition ofmAb5AB3-11 (15), followed by a biotinylated
anti-mouse IgM (Sigma), extravidin-alkaline phosphatase
and 1 mg/ml 4-nitrophenyl phosphate. Absorbance was mea-
sured on a microplate reader at 405 nm.
Immunoprecipitations of PrP-specific Rafts—Treated cells
were homogenized in ice cold 1% Triton X-100, 10 mM Tris-
HCl, pH 7.2, 100 mM NaCl, 10 mM EDTA at 106 cells/ml. Cell
debris was removed from by centrifugation (1000  g for 5
min), and the supernatant was incubated with a mAb to PrP
(4F2) for 30 min at 4 °C on rollers. Magnetic microbeads con-
taining protein G (Miltenyi Biotech) were added (10 l/ml) for
30min, and proteinG-bound antibody complexeswere isolated
using a MACS magnetic system (Miltenyi Biotech) at 4 °C.
The amounts of sialylated gangliosides in precipitates were
determined by diluting precipitates from 106 cells in 1 ml of
carbonate buffer and plating in Maxisorb immunoplates over-
night. The plates were blocked with 5% milk powder in PBS-
Tween, and sialylated gangliosides were detected by the
addition of biotinylated S. nigra lectin followed by extravidin-
alkaline phosphatase and 1 mg/ml 4-nitrophenyl phosphate.
Absorbance was measured on a microplate reader at 405 nm.
Gangliosides within immunoprecipitates were separated by
HPTLC in a solvent containing chloroform/methanol/water
(6/4/1 v/v/v). Plates were blocked, and sialic acid containing
gangliosides were detected by incubation with biotinylated
S. nigra lectin, extravidin-peroxidase, and chemiluminesence.
Western Blot—Samples were dissolved in 50 l of Laemmli
buffer, boiled, and subjected to electrophoresis on a 15% poly-
acrylamide gel. Proteins were transferred onto a Hybond-P
PVDF membrane (Amersham Biosciences) by semidry blot-
ting. Membranes were blocked using 10% milk powder in PBS
containing 0.2%Tween 20. PrPwas detected by incubationwith
mAb ICSM18, -actin bymAbAC-74 (Sigma), and cPLA2 with
mAb CH-7, followed by a secondary anti-mouse IgG conju-
gated to peroxidase. Bound antibody was visualized by
chemiluminescence.
Cholesterol and Protein Content—Cholesterol and protein
content were determined in cell membrane extracts. Pro-
tein concentrations were measured using amicro-BCA protein
assay kit (Pierce). The concentrations of cholesterol were mea-
sured using the Amplex Red cholesterol assay kit (Invitrogen).
Cholesterol is oxidized by cholesterol oxidase to yield hydrogen
peroxide, which reacts with 10-acetyl-3,7-dihydroxyphenoxa-
zine (Amplex Red reagent) to produce highly fluorescent reso-
rufin. Fluorescence was measured by excitation at 550 nm and
emission detection at 590 nm. The concentration of cholesterol
was calculated by reference to cholesterol standards.
Statistical Analysis—Comparison of treatment effects was
carried out using Student’s paired t-tests, one-way and two-way
analysis of variance with Bonferroni’s post hoc tests (IBM SPSS
statistics 20). Error values are S.D., and significance was deter-
mined, where p  0.01. Correlations between data sets were
analyzed using Pearson’s bivariate coefficient (IBMSPSS statis-
tics 20).
Results
Deglycosylated PrPC Is Converted to PrPSc—Initial studies
were performed to determine whether the N-linked glycans
that are attached to PrPC affect PrPSc formation in ScGT1 cells.
N-Linked glycans were removed from PrPC by digestion with
endoglycosidase F (16) (Fig. 1A), and deglycosylated PrPC was
isolated on C18 columns (Fig. 1B). The addition of PrPC
or endoglycosidase F-digested PrPC (deglycosylated PrPC)
increased the PrPSc content of ScGT1 cells in a dose-dependent
manner (Fig. 1C); there were no significant differences in the
amounts of PrPSc in cells incubated with PrPC or with deglyco-
sylated PrPC. Similarly, the addition of 10 ng deglycosylated
PrPC increased the amount of PrPSc in ScN2a cells (4.7 ng
PrPSc/106 cells 1.1 compared with 1.5 ng PrPSc 0.7, n 15,
p  0.05). Because the absence of N-linked glycans did not
significantly affect PrPSc formation in these cells, all the follow-
ing experiments were performed with deglycosylated PrPC
preparations.
Sialic Acid on the GPI Anchor of PrPC Is Necessary for PrPSc
Formation—The GPI anchor attached to PrPC is unusual for
mammalian GPIs in that it contains sialic acid as first described
by Stahl et al. (12) and illustrated in Fig. 2A. To confirm the
presence of sialic acid in our PrPC preparations, GPIs were iso-
lated from PrPC and desialylated PrPC (neuraminidase-di-
gested) by reverse phase chromatography (Fig. 2B). GPIs
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derived from PrPC and desialylated PrPC eluted at different
concentrations of propanol. HPTLC analysis confirmed that
neuraminidase digestion altered the migration of the GPI iso-
lated from PrPC consistent with the loss of sialic acid (Fig. 2C).
Isolated GPIs were blotted onto nitrocellulose membranes and
probed with mAb 5AB3-11 and biotinylated lectins. The diges-
tion of PrPC with neuraminidase did not affect the binding of
mAb 5AB3-11 (binds to phosphatidylinositol) or concanavalin
A (binds to mannose) to the GPIs, showing that similar
amounts of GPIs were added to blots. S. nigra lectin (which
reacts with terminal sialic acid bound either -2,6 or -2,3 to
galactose) bound to GPIs isolated from PrPC, but not to GPIs
derived from neuraminidase-digested PrPC, indicating that
sialic acid had been removed (Fig. 2D). The lectin R. communis
agglutinin I bound to neuraminidase-digested GPIs, indicating
that terminal galactose had been exposed.
The observation that PrPSc does not replicate in Prnp(0/0)
neurons (14) allowed us to examine whether desialylated PrPC
was converted to PrPSc. Both PrPC and desialylated PrPC bound
readily to recipient Prnp(0/0) neurons; following the addition of
10-ng PrPC preparations for 2 h, there was no significant differ-
ence in the amounts of PrPC and desialylated PrPC bound (9.4
ng of PrPC  0.9 compared with 9.7 ng  0.9, n  9, p  0.7).
Neurons from Prnp(0/0) mice were pulsed with 1 ng of PrPSc for
2 h and incubated with culture media containing control
medium, 10 ng of PrPC, or 10 ng of desialylated PrPC. Media
containing the PrPC/desialylated PrPCwas replaced daily for 10
dayswhen the amounts of PrPSc in neuronsweremeasured.We
did not detect any PrPSc in neurons that had been pulsed with 1
ng of PrPSc and incubatedwith controlmedium, suggesting that
original inoculum was degraded by these neurons. However,
PrPSc pulsed neurons incubated daily with 10 ng PrPC con-
tained 25.7 ng of PrPSc 4.2,n 12, indicating that some of the
added PrPC was converted to PrPSc. In contrast, no PrPSc was
detected in neurons pulsed with 1 ng of PrPSc and incubated
daily with 10 ng of desialylated PrPC, indicating that it was not
converted to PrPSc (Fig. 3A). Immunoblots confirmed the
ELISA data and showed that PrPSc was formed in Prnp(0/0) neu-
rons pulsedwith PrPSc and incubated daily with PrPC but not in
neurons pulsed with PrPSc and incubated daily with control
medium or with desialylated PrPC (Fig. 3B).
Desialylated PrPC Reduced PrPSc Formation—Next, the
effects of desialylated PrPC on the conversion of endogenous
PrPC to PrPSc were determined. For this study, neurons derived
from Prnp(/) mice were pulsed with 1 ng of PrPSc for 2 h and
incubated for a further 10 days with 10 ng of PrPC or 10 ng of
desialylated PrPC. Neurons pulsed with PrPSc and incubated in
control medium contained 40.2 ng of PrPSc 5.2, n 12. The
addition of PrPC increased the amount of PrPSc in neurons to
68.5 ng of PrPSc 7.1, n 12, whereas the addition of desialy-
lated PrPC reduced the amount of PrPSc to 5.2 ng/ml (Fig. 4, A
FIGURE 1.N-Linkedglycans did not affect the conversion of PrPC to PrPSc.
A, immunoblot showing PrPC (lane 1) and deglycosylated PrPC (lane 2) sepa-
rated by PAGE. B, the amounts of deglycosylated PrPC (●) in fractions from
C18 columns eluted under a gradient of propanol and water. C, the amounts
of PrPSc in ScGT1 cells treated daily with concentrations of PrPC () or degly-
cosylated PrPC (f) as shown for 7 days. The values are means  S.D. from
triplicate experiments performed four times (n 12).
FIGURE 2. Neuraminidase removed the sialic acid from the GPI anchor
attached to PrPC. A, cartoon showing the putative structures of the GPI
anchor attached to PrPC and the desialylated PrPC. Glycan residues shown
include mannose (Man), sialic acid (SA), galactose (Gal), inositol (Inos),
N-acetyl galactosamine (GalNAc), and glucosamine (GlcN). B, GPIs isolated
from PrPC (E) and desialylated PrPC (●) were separated by reverse phase
chromatography using a C18 column. GPIs were detectedwithmAb 5AB3-11
reactive with phosphatidylinositol. C, HPTLC showing the migration of GPIs
derived from PrPC (lane 1) or desialylated PrPC (lane 2) separated on silica 60
plates.D, dot blots showing the binding ofmAb 5AB3-11 (phosphatidylinosi-
tol), biotinylated concanavalin A (mannose), biotinylated S. nigra lectin (sialic
acid), and biotinylated R. communis agglutinin I (galactose) to GPI anchors
isolated from PrPC or desialylated PrPC.
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and B), indicating that desialylated PrPC suppressed the con-
version of PrPC to PrPSc. Furthermore, when neurons from
Prnp(0/0) mice were pulsed with 1 ng of PrPSc and incubated
with 10 ng of PrPC or a mixture of 10 ng of PrPC and 10 ng of
desialylated PrPC for 10 days the presence of desialylated PrPC
reducedPrPSc production (Fig. 4C). Similarly, the daily addition
of desialylated PrPC reduced the PrPSc content of recipient
ScN2a cells (Fig. 4D) and ScGT1 cells (Fig. 4E).
Sialic Acid on the GPI Anchor Affects the Fate of PrPC—To
determine the mechanism(s) involved in desialylated PrPC-in-
duced suppression of PrPSc formation, its properties in nonin-
fected cells were examined. Both PrPC and desialylated PrPC
bound readily to recipient Prnp(0/0) neurons. The targeting of
PrPC toDRMs is necessary for efficient prion formation (4), and
following the addition of 10-ng PrPC preparations, similar
amounts of PrPC and desialylated PrPC were found within
DRMs (8.2 ng of PrPC  0.9 compared with 8.1 ng of desialy-
lated PrPC  1.2, n  9, p  0.7). PrPC and desialylated PrPC
were found within different membrane rafts; after Prnp(0/0)
neurons pulsed with 10 ng of PrPC or 10 ng of desialylated PrPC
were homogenized in ice-cold Triton X-100 (which maintains
the integrity of membrane rafts) and subjected to sucrose den-
sity gradient analysis; the desialylated PrPC was found in lower
density rafts than those containing PrPC (Fig. 5A). These rafts
were examined in detail after immunoprecipitation. Similar
amounts of PrPC and desialylated PrPC were obtained in each
precipitate (Fig. 5B). However, the rafts isolated with PrPC con-
tained significantly less cholesterol than rafts surrounding
desialylated PrPC (Fig. 5C). HPTLC analysis of immunoprecipi-
tates demonstrated that rafts containing desialylated PrPC con-
tained more sialylated gangliosides than did membranes sur-
rounding PrPC (Fig. 5D). ELISA studies confirmed that rafts
co-precipitated with desialylated PrPC contained significantly
more sialylated gangliosides than rafts co-precipitated with
PrPC (Fig. 5E).
Reducing cellular cholesterol concentrations destabilized
some rafts, resulting in the relocation of PrPC from rafts to
detergent-solublematerials (4). Here we examinedwhether the
targeting of desialylated PrPC to DRMs was also sensitive to
cholesterol depletion. Prnp(0/0) neurons pretreated with the
cholesterol synthesis inhibitor squalestatin for 24 hwere pulsed
with 10 ng of PrPC or 10 ng of desialylated PrPC and DRMs
FIGURE 3. Desialylated PrPC is not converted to PrPSc. A, the amounts of
PrPSc in Prnp(0/0) neurons pulsed with 1 ng of PrPSc and incubated daily with
control medium, 10 ng of PrPC, or 10 ng of desialylated PrPC for 10 days. The
values are means  S.D. from triplicate experiments performed four times
(n  12). B, immunoblots showing the amounts of -actin and PrPSc in
extracts of Prnp(0/0) neurons pulsed with 1 ng of PrPSc and incubated daily
with control medium (lane i), 10 ng of PrPC (lane ii), or 10 ng of desialylated
PrPC (lane iii) for 10 days.
FIGURE 4. Desialylated PrPC inhibited PrPSc formation. A, the amounts of
PrPSc in Prnp(/) neurons pulsedwith 1 ng of PrPSc and incubated daily with
controlmedium(), 10ngofPrPCor 10ngofdesialylatedPrPC (f) for 10days.
The values means  S.D. from triplicate experiments performed four times
(n 12). B, immunoblots showing amounts of-actin and protease-resistant
PrP in neurons pulsed with 1 ng of PrPSc and incubated daily with control
medium (lane 1), 10 ngof PrPC (lane 2), or 10ngof desialylatedPrPC (lane 3) for
10 days. C, the amounts of PrPSc in Prnp(0/0) neurons pulsedwith 1 ng of PrPSc
and incubated daily with control medium, 10 ng of PrPC, or a combination of
10 ng of PrPC and 10 ng of desialylated PrPC for 10 days. The values are
means S.D. from triplicate experiments performed four times (n 12). D,
the amounts of PrPSc in ScN2a cells treated daily with control medium () or
desialylated PrPC (f) as shown for 7 days. The values are means S.D. from
triplicate experiments performed four times (n 12). E, the amounts of PrPSc
in ScGT1 cells treated daily with control medium () or desialylated PrPC (f)
as shown for 7 days. The values aremeans S.D. from triplicate experiments
performed four times (n 12).
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(rafts) isolated. Whereas squalestatin reduced the amounts of
PrPC in rafts, desialylated PrPC remained within rafts (Fig. 6A).
The concentrations of cholesterol within cell membranes were
reduced by squalestatin in a dose-dependent manner. There
was a significant correlation between amounts of raft PrPC, but
not desialylated PrPC, and concentrations of cholesterol in
squalestatin-treated cells (Fig. 6B). Neurons incubated with
PrPC/desialylated PrPC were also treated with PI-PLC for 1 h.
Although digestion with PI-PLC reduced the amounts of cell-
associated desialylated PrPC to less than 0.5 ng (indicating that
all desialylated PrPC was expressed at the cell surface), 3.6 ng of
PrPC  0.4 remained cell-associated after PI-PLC digestion
(Fig. 6C). Increasing the concentration of PI-PLC, or incubation
period, did not affect the amounts of cell-associated PrPC, sug-
gesting that there is a pool of PrPC that is not expressed at the
surface of neurons. Because proteins with different GPI
anchors traffic via different pathways (17, 18), the effect of the
GPI anchor on the fate of PrPC within cells was investigated.
FIGURE 5. Sialic acid on the GPI affects the composition of membrane
rafts.Prnp(0/0) neuronswerepulsedwith25ngofPrPCor 25ngofdesialylated
PrPC and homogenized in ice-cold Triton X-100. A, the amounts of PrPC ()
and desialylated PrPC (f) in membranes separated on a sucrose density gra-
dient. The values aremeans S.D. fromanexperiment run in triplicate.Mem-
brane rafts containing PrPCwere isolated by precipitationwith the PrPC-reac-
tive mAb 4F2. B, blots showing the amounts of PrPC and desialylated PrPC in
immunoprecipitates.C, the concentrations of cholesterol in precipitates from
PrPC () or desialylated PrPC (f). The values are means  S.D. from four
precipitates, each measured in triplicate (n 12). *, cholesterol significantly
higher than in PrPC precipitates (p 0.05).D, gangliosides in immunoprecipi-
tates from cells incubated with PrPC (lane 1) or desialylated PrPC (lane 2) sep-
arated by HPTLC on silica 60 plates. E, the concentrations of gangliosides in
precipitates of PrPC () or desialylated PrPC (f). The values are means S.D.
from four precipitates, each measured in triplicate (n  12). *, gangliosides
significantly higher than in PrPC precipitates (p 0.05).
FIGURE 6. Sialic acid on the GPI anchor affects the stability of PrPC. A, the
amounts of PrPC in rafts (DRMs) fromPrnp(0/0) neurons pretreatedwith squal-
estatin as shownandpulsedwith 10ngof PrPC () or desialylatedPrPC (f) for
2 h. The values are means S.D. from triplicate experiments performed four
times (n  12). *, significantly less PrPC in rafts. B, there was a significant
correlation between concentrations of cholesterol and concentrations of
PrPC (E), but not desialylated PrPC (●), in rafts derived from Prnp(0/0) neurons
pretreated with squalestatin and pulsed with 10 ng of PrPC/desialylated PrPC
for 2 h, Pearson’s coefficient  0.41, p  0.01. C, the amounts of PrPC in
Prnp(0/0) neurons pulsedwith 10 ng of PrPC () or desialylated PrPC (f) for 2 h
and incubatedwith controlmediumor PI-PLC for 1 h. The values aremeans
S.D. from triplicate experiments performed three times (n 9). *, significantly
less desialylated PrPC after digestion with PI-PLC. D, the amounts of PrPC
remainingPrnp(0/0) neuronspulsedwith10ngof PrPC () or desialylatedPrPC
(f) measured at time points thereafter. The values are means  S.D. from
triplicate experiments performed three times (n  9). *, significantly more
desialylated PrPC remaining in neurons. E, the amounts of PrPC in Prnp(0/0)
neurons incubated for 2 hwith 10 ng of PrPC () or 10 ng of desialylated PrPC
(f) and treated with control medium or 5 M glimepiride for 1 h. The values
are means S.D. from triplicate experiments performed three times (n 9).
*, significantly less PrPC in neurons after treatment with glimepiride.
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Prnp(0/0) neurons were pulsed with 10 ng of PrPC preparations,
and the amounts of PrPC were measured at time points there-
after. Whereas PrPC was rapidly cleared from neurons and was
absent after 48 h, desialylated PrPC remained in neurons for up to
96h (Fig. 6D). SomeGPI-anchoredproteins are released fromcells
following the glimepiride-induced activation of an endogenous
GPI-PLC (19, 20). Treatment with 5 M glimepiride caused the
release of PrPC but not desialylated PrPC (Fig. 6E).
Desialylated PrPC Reduced the Activation of cPLA2 in Prion-
infected Cells—Because the concentration of cholesterol within
cell membranes affects PrPSc formation (4), the effects of PrPC
and desialylated PrPC on cholesterol in prion-infected cells
were also examined. The amount of cholesterol in ScGT1 cell
membraneswas significantly increased after incubationwith 10
ng of PrPC (744 ng of cholesterol/106 cells 84 compared with
534  48, n  9, p  0.05) or with 10 ng of desialylated PrPC
(771 ng of cholesterol/106 cells 76 compared with 534 48,
n 9, p 0.05). Critically there was no significant difference in
the amounts of cholesterol between ScGT1 cells treated with
PrPC or with desialylated PrPC (744 ng of cholesterol/106
cells 84 compared with 771 76, n 9, p 0.36).
Because PrPSc formation is dependent upon the activation of
cPLA2 (21), the effects of desialylated GPI on this enzyme were
studied. The addition of 25 ng of desialylated PrPC significantly
reduced the amounts of activated cPLA2 in both ScN2a and
ScGT1 cells (Table 1).However, desialylated PrPC did not affect
PLAP-induced activation of cPLA2, showing that it did not have
a direct effect upon cPLA2. The possibility that the addition of
PLAP could restore PrPSc formation in cells treated with desia-
lylated PrPCwas investigated. PrPScwas not detected in ScGT-1
cells treated with a combination of 25 ng of desialylated PrPC
and 1M PLAP (PrPSc0.05 ng/106 cells), showing that nonse-
lective activation of cPLA2 was not sufficient to reverse desia-
lylated PrPC-induced suppression of PrPSc formation.
The clustering of GPIs in the membrane that arises as a con-
sequence of the self-aggregation of PrPSc molecules can be
mimicked by mAb-mediated cross-linkage of PrPC, which also
activates cPLA2 (22).When Prnp(0/0) neurons were pulsed with
PrPC or desialylated PrPC and incubated with mAb 4F2 cross-
linkage of PrPC, but not desialylated PrPC, it caused a dose-de-
pendent increase in activated cPLA2 (Fig. 7A). Furthermore,
when Prnp(/) neurons were pulsed with desialylated PrPC
and incubatedwithmAb4F2 to cross-link PrPC, the presence of
desialylated PrPC reduced activated cPLA2 in a dose-dependent
manner (Fig. 7B).
Sialic Acid on the GPI Anchor Stabilized cPLA2 within PrP-
containing Rafts—Upon activation, cPLA2 migrates from the
cytoplasm to rafts (9, 23). Sucrose density gradients showed
that in untreated ScGT1 cells, most of the cPLA2 was in low
density membranes (fractions 9–12), whereas in cells that had
been incubated with 25 ng of desialylated PrPC, a proportion of
cPLA2 had relocated to fractions 4–7 (Fig. 8A). Immunopre-
cipitation studies showed that cPLA2 was found within PrPSc-
containing rafts (9), raising the possibility that the sialic acid
moiety on the GPI attached to PrPC or PrPSc is required to
capture cPLA2 within lipid rafts. This hypothesis was tested by
treating Prnp(/) neuronswith 10 ng of PrPC or 10 ng of desia-
lylated PrPC followed by the cross-linkage of PrPC bymAb 4F2.
Although precipitates contained similar amounts of PrPC, the
precipitates fromneurons incubatedwith PrPC containedmore
cPLA2 than precipitates from neurons containing desialylated
PrPC (Fig. 8B).
Discussion
Recent studies suggest that differential glycosylation of the
GPI anchor can affect the properties of some proteins, includ-
ing protein structure (24),membrane localization, and intracel-
lular trafficking (25). Here we show that sialic acid in the GPI
affected the composition of the membranes surrounding PrPC,
cell signaling, and the conversion of PrPC to PrPSc.
Desialylated PrPC was created by the sequential digestion of
PrPC with a endoglycosidase F (to remove N-linked glycans)
TABLE 1
Sialic acid in the GPI anchor affected prion-mediated activation of
cPLA2
The amounts of activated cPLA2 in cell extracts from ScN2a or ScGT1 cells pre-
treated with control medium or with 25 ng of desialylated PrPC and then incubated
with 1 M PLAP for 1 h. The values are the means  S.D. from triplicate experi-
ments performed five times (n 15). The amount of activated cPLA2 in untreated
cells was standardized as 1 for each cell line.
Treatment
Activated cPLA2
ScN2a cells ScGT1 cells
units/106 cells
None 1.0 0.14 1.0 0.11
Desialylated PrPC 0.48 0.12 0.6 0.18
PLAP 3.87 0.58 2.42 0.28
Desialylated PrPC PLAP 3.52 0.49 2.22 0.29
FIGURE 7.Desialylated PrPC reduces activation of cPLA2 by cross-linkage
of PrPC. A, the amounts of activated cPLA2 in Prnp
(0/0) neurons pretreated
with PrPC () or desialylated PrPC (f) as shown and incubatedwithmAb 4F2.
The values are means  S.D. from triplicate experiments performed three
times (n  9). B, the amounts of activated cPLA2 in Prnp
(/) neurons pre-
treated with desialylated PrPC as shown and incubated with mAb 4F2. The
values are means  S.D. from triplicate experiments performed three times
(n 9).
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followed by neuraminidase to remove sialic acid. The removal
ofN-linked glycanswas necessary to show that the effects of the
subsequent neuraminidase digestion was upon sialic acid con-
tained within the GPI anchor and not due to the removal of
sialic acid containedwithin theN-linked glycans. Prnp(0/0) neu-
rons exposed to PrPSc demonstrated that although PrPC was
converted to PrPSc, desialylated PrPC was not. Consequently,
the factors that prevented the conversion of desialylated PrPC
to PrPSc were examined. Both PrPC and desialylated PrPC
bound to recipient cells, increased the concentrations of cho-
lesterol in cellmembranes, andwere targeted to rafts. However,
membrane rafts are heterogeneous (26), and the composition of
theGPI anchor is thought to target proteins to specific rafts. For
example, PrPC and Thy-1 have different GPI anchors and are
targeted to different rafts (27), and replacing the GPI of PrPC
with that of Thy-1 altered the trafficking of PrPC to apicalmem-
branes (28). Therefore, it is possible that the differences in their
GPIs direct PrPC and desialylated PrPC to different rafts and
consequently their trafficking within cells.
GPI-anchored proteins are surrounded by specific phospho-
lipids, glycolipids, and cholesterol that constitute a raft, the
composition of which is dependent upon multiple interactions
between the protein, glycans, andmembrane lipids (29). Thus, a
change in the composition of the GPI anchor attached to a
protein could affect the composition of the surrounding raft.
This hypothesis is supported by observations that the compo-
sition of GPIs attached to Thy-1 differs from those attached to
PrPC (12, 30), and themembranes surrounding thesemolecules
have different lipid compositions (31).We hypothesize that the
presence of sialic acid in the GPI has a direct effect upon the
composition of the surrounding membrane rafts as illustrated
in Fig. 9 (A and B). Our observation that the rafts surrounding
desialylated PrPC contained more cholesterol and sialylated
gangliosides than those surrounding PrPC supported this
hypothesis. In addition, treatment with glimepiride caused the
release of PrPC, but not desialylated PrPC, suggesting that only
PrPC is associated with a raft containing endogenous GPI-PLC.
How sialic acid affects the composition of rafts is unknown.
One possibility is that the sialic acid contained within the GPI
competes with gangliosides for sialic acid-binding proteins
within rafts. Thus, the removal of sialic acid from theGPIwould
allow the incorporation of gangliosides, which are associated
with the suppression of PrPSc formation (32), into rafts. Gan-
gliosides help sequester cholesterol and stabilize rafts (33, 34)
especially in brain tissue (35). The increased amounts of gan-
gliosides that surround desialylated PrPC would be expected to
forma raft containingmore cholesterol, aswas demonstrated in
these experiments. The concentrations of cholesterol in cell
membranes affectsmembrane rigidity and helps stabilizemem-
brane rafts (36). We noted that desialylated PrPC remained
within rafts in cholesterol-depleted cells, whereas PrPC was
FIGURE 8.DesialylatedPrPC reduced the targetingof cPLA2 to rafts.A, the
amounts of cPLA2 in membrane extracts separated on a sucrose density gra-
dient from ScGT1 cells treated with control medium () or 25 ng of desialy-
lated PrPC (f). The values are means S.D. from an experiment run in tripli-
cate. B, immunoblots showing amounts of PrPC and cPLA2 precipitated by
mAb 4F2 (reactivewith PrPC) fromwild type Prnp(/) neurons treated for 3 h
with control medium or 25 ng of desialylated PrPC.
FIGURE 9. PrPCwith sialic acidmay alter the underlying cellmembrane. A
and B, schematic showing the proposed membranes surrounding PrPC (A)
and desialylated PrPC (B) that include cholesterol, saturated phospholipids,
unsaturated phospholipids, and gangliosides. C, proposed interactions
between PrPC and PrPSc and its effects on the surroundingmembrane includ-
ing the incorporation of cPLA2 into membranes. D, proposed interactions
between desialylated PrPC and PrPSc and its effects on the surroundingmem-
brane including gangliosides.
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relocated to detergent-soluble materials, a finding indicating
that the rafts surrounding desialylated PrPC are more choles-
terol-dense and hence more resistant to cholesterol depletion
than those surrounding PrPC. Such observations are compati-
ble with reports that the amount of gangliosides in rafts affects
the expression and function of some GPI-anchored proteins
(37, 38) including PrPC (39).
Our observation that desialylated PrPC remained in cells lon-
ger than PrPC suggests that sialic acid in the GPI anchor affects
the trafficking of PrPC. The endocytosis of PrPC involves a step
in which it moves out of rafts and enters clathrin-coated pits
(17, 40). We speculate that desialylated PrPC stabilized within
cholesterol-dense rafts does not to move out of rafts nor
undergo the same endocytic process as PrPC. It is possible that
the cellular location of desialylated PrPC results in reduced
interactions with PrPSc, which would explain why desialylated
PrPC was not converted to PrPSc.
Desialylated PrPC also inhibited the conversion of endoge-
nous PrPC to PrPSc in primary cortical neurons and ScN2a and
ScGT1 cells. Previously we had shown that monoacylated PrPC
reduced prion formation (9), and others have demonstrated
that co-expression of mutant prion proteins alters the cellular
localization of wild type PrPC and portioning into DRMs/rafts
(41). One possibility is that desialylated PrPC competes with
endogenous PrPC for specific partner proteins involved in
endocytosis and that the depletion of these partner proteins
alters the trafficking of endogenous PrPC and hence PrPSc for-
mation.Herewe explored the concept that the binding of desia-
lylated PrPC to PrPSc modifies the rafts that are involved in
PrPSc formation (3). The composition andhence the function of
rafts is dynamic and controlled by an “induced fit” model (26).
Because the composition of membranes is affected by the gly-
can structure of GPIs (29, 31), the membrane surrounding a
complex between PrPSc and PrPC (Fig. 9C) would be expected
to differ from membranes surrounding PrPSc and desialylated
PrPC (Fig. 9D). Studies in T and B cell receptor signaling show
that the coalescence of raft outermembrane proteins affects the
composition of the cytoplasmic leaflet and its association with
signaling molecules (42–45). We propose that the binding of
desialylated PrPC to PrPSc changes the composition of the local
membrane so that it is unfavorable for the conversion of PrPC to
PrPSc.
The hypothesis that the clustering of sialic acid-containing
GPIs attached to PrP leads to the activation of cPLA2, a factor
that promotes PrPSc formation (21), was explored. This occurs
naturally as a consequence of PrPSc self-aggregation and exper-
imentally following cross-linkage of PrPC by mAbs. Whereas
cross-linkage of PrPC activated cPLA2, cross-linkage of desialy-
lated PrPC had no affect, demonstrating that sialic acid was
required (13). Cross-linkage of a mixture of PrPC and desialy-
lated PrPC reduced activation of cPLA2 when compared with
cross-linkage of PrPC alone (13), indicating that homogeneity of
the GPI anchors was critical. Notably the presence of desialy-
lated PrPC did not affect the activation of cPLA2 by PLAP, indi-
cating that it did not have a direct effect upon this enzyme.
To understand how desialylated PrPC inhibited activation of
cPLA2, the cellular location of cPLA2 was examined. The acti-
vation of cPLA2 causes it to migrate from the cytoplasm to
membrane rafts (23). In control ScGT1 cells, activated cPLA2
was found predominantly in rafts, and more specifically cPLA2
co-localized to PrPSc-containing rafts (9). The addition of
desialylated PrPC caused the dissociation of cPLA2 from rafts.
The targeting of cPLA2 to membranes containing their sub-
strates can regulate the formation of secondmessengers such as
platelet-activating factor that facilitate PrPSc formation (21).
We propose that the density of sialic acid attached to GPIs is
critical to the stabilization and activation of cPLA2 in mem-
brane rafts and that the binding of desialylated PrPC to PrPSc
changed the composition of the underlyingmembrane so that it
no longer captured and activated cPLA2. This reduced the acti-
vation of cPLA2 by existing PrPSc and hindered the conversion
of PrPC to PrPSc. It is noteworthy that desialylated PrPC is sur-
rounded by more gangliosides than PrPC, which is consistent
with reports that gangliosides inhibit the activation of cPLA2
(46–48).
Some of the PrPC extracted from hamster brains have GPIs
that did not contain sialic acid (12). The chemical composition
of the GPI anchor is cell type-specific 49), and the GPI anchor
attached to PrPC derived from a glial cell line (N9 cells) does not
contain sialic acid (13). More recently we found that some neu-
ronal cell lines produce predominantly desialylated PrPC, sug-
gesting that these cells may be resistant to prion infection, an
observation that may explain the different sensitivities of neu-
rons to prion infection.
In conclusion, we show that sialic acid attached to the GPI
affects the properties of PrPC, altering the surrounding cell
membrane, trafficking of PrPC, and PrPC-induced cell signal-
ing. Critically the presence of desialylated PrPC reduced the
activation of cPLA2 and PrPSc formation in prion-infected neu-
ronal cells. We propose that sialic acid on the GPI anchor
attached to PrPC affects the membrane targeting and cell sig-
naling that is conducive to its conversion to PrPSc. Conse-
quently, therapeutics that block the incorporation of sialic acid
into GPI anchors could prove useful in the treatment of prion
diseases.
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